Medifast, Inc. (MED) Tops Q4 EPS by 3c; Issues Mixed Outlook
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.63 +0.72%
EPS Growth %: -195.2%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
PMCB, CULP, HURC, More
EPS Growth %: -195.2%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $82.9 million.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Lululemon (LULU) PT Lowered to $115 at Freedom Broker
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
